Isolated Malignant Melanoma Metastasis to the Pancreas

por Larsen, Anne K., Krag, Christen, Geertsen, Poul, Jakobsen, Linda P.
Publicado 2013

Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region

por Sibolt, Patrik, Andersson, Lina M., Calmels, Lucie, Sjöström, David, Bjelkengren, Ulf, Geertsen, Poul, Behrens, Claus F.
Publicado 2020

Single-isocenter stereotactic non-coplanar arc treatment of 200 patients with brain metastases: multileaf collimator size and setup uncertainties

por Calmels, Lucie, Blak Nyrup Biancardo, Susan, Sibolt, Patrik, Nørring Bekke, Susanne, Bjelkengren, Ulf, Wilken, Eva, Geertsen, Poul, Sjöström, David, Behrens, Claus F.
Publicado 2021

A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

por Soerensen, Anne V., Geertsen, Poul F., Christensen, Ib J., Hermann, Gregers G., Jensen, Niels V., Fode, Kirsten, Petersen, Astrid, Sandin, Rickard, Donskov, Frede
Publicado 2016

Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer

por Calmels, Lucie, Sibolt, Patrik, Åström, Lina M., Serup-Hansen, Eva, Lindberg, Henriette, Fromm, Anna-Lene, Persson, Gitte, Sjöström, David, Geertsen, Poul, Behrens, Claus P.
Publicado 2022

Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study

por Nyholm, Tufve, Jonsson, Joakim, Söderström, Karin, Bergström, Per, Carlberg, Andreas, Frykholm, Gunilla, Behrens, Claus F, Geertsen, Poul Flemming, Trepiakas, Redas, Hanvey, Scott, Sadozye, Azmat, Ansari, Jawaher, McCallum, Hazel, Frew, John, McMenemin, Rhona, Zackrisson, Björn
Publicado 2013

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

por Powles, Thomas, Motzer, Robert J., Escudier, Bernard, Pal, Sumanta, Kollmannsberger, Christian, Pikiel, Joanna, Gurney, Howard, Rha, Sun Young, Park, Se Hoon, Geertsen, Poul F., Gross-Goupil, Marine, Grande, Enrique, Suarez, Cristina, Markby, David W., Arroyo, Alan, Dean, Mark, Choueiri, Toni K., George, Daniel
Publicado 2018

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

por McDermott, David F., Lee, Jae-Lyun, Bjarnason, Georg A., Larkin, James M. G., Gafanov, Rustem A., Kochenderfer, Mark D., Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S., Alonso-Gordoa, Teresa, Cho, Daniel C., Geertsen, Poul F., Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
Publicado 2021

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random...

por Motzer, Robert J, Escudier, Bernard, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Powles, Thomas, Donskov, Frede, Plimack, Elizabeth R, Barthélémy, Philippe, Hammers, Hans J, George, Saby, Grünwald, Viktor, Porta, Camillo, Neiman, Victoria, Ravaud, Alain, Choueiri, Toni K, Rini, Brian I, Salman, Pamela, Kollmannsberger, Christian K, Tykodi, Scott S, Grimm, Marc-Oliver, Gurney, Howard, Leibowitz-Amit, Raya, Geertsen, Poul F, Amin, Asim, Tomita, Yoshihiko, McHenry, M Brent, Saggi, Shruti Shally, Tannir, Nizar M
Publicado 2021